Roquefort Therapeutics plc ROQ.L Stock
Roquefort Therapeutics plc Price Chart
Roquefort Therapeutics plc ROQ.L Financial and Trading Overview
| Roquefort Therapeutics plc stock price | 4.55 GBP |
| Previous Close | 6.75 GBP |
| Open | 0 GBP |
| Bid | 6.5 GBP x N/A |
| Ask | 0 GBP x N/A |
| Day's Range | 0 - 0 GBP |
| 52 Week Range | 0 - 11.75 GBP |
| Volume | 558.71K GBP |
| Avg. Volume | 101.28K GBP |
| Market Cap | 8.88M GBP |
| Beta (5Y Monthly) | -0.035613 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 GBP |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ROQ.L Valuation Measures
| Enterprise Value | 6.39M GBP |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 120.53571 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Roquefort Therapeutics plc Stock Price History
| Beta (5Y Monthly) | -0.035613 |
| 52-Week Change | -15.62% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 11.75 GBP |
| 52 Week Low | 0 GBP |
| 50-Day Moving Average | 4.26 GBP |
| 200-Day Moving Average | 6.53 GBP |
ROQ.L Share Statistics
| Avg. Volume (3 month) | 101.28K GBP |
| Avg. Daily Volume (10-Days) | 152.27K GBP |
| Shares Outstanding | 129.15M |
| Float | 64.31M |
| Short Ratio | N/A |
| % Held by Insiders | 28.69% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -16.57% |
| Return on Equity (ttm) | -28.61% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -1615417 GBP |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.32M GBP |
| Total Cash Per Share (mrq) | 0.02 GBP |
| Total Debt (mrq) | 0 GBP |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 8.67 |
| Book Value Per Share (mrq) | 0.056 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1577476 GBP |
| Levered Free Cash Flow (ttm) | 1.15M GBP |
Profile of Roquefort Therapeutics plc
| Country | United Kingdom |
| State | N/A |
| City | London |
| Address | Eccleston Yards |
| ZIP | SW1W 9NF |
| Phone | 44 20 3290 9339 |
| Website | https://www.roquefortinvest.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 9 |
Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer. Roquefort Therapeutics plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
Q&A For Roquefort Therapeutics plc Stock
What is a current ROQ.L stock price?
Roquefort Therapeutics plc ROQ.L stock price today per share is 4.55 GBP.
How to purchase Roquefort Therapeutics plc stock?
You can buy ROQ.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Roquefort Therapeutics plc?
The stock symbol or ticker of Roquefort Therapeutics plc is ROQ.L.
Which industry does the Roquefort Therapeutics plc company belong to?
The Roquefort Therapeutics plc industry is Biotechnology.
How many shares does Roquefort Therapeutics plc have in circulation?
The max supply of Roquefort Therapeutics plc shares is 1.29M.
What is Roquefort Therapeutics plc Price to Earnings Ratio (PE Ratio)?
Roquefort Therapeutics plc PE Ratio is now.
What was Roquefort Therapeutics plc earnings per share over the trailing 12 months (TTM)?
Roquefort Therapeutics plc EPS is 0 GBP over the trailing 12 months.
Which sector does the Roquefort Therapeutics plc company belong to?
The Roquefort Therapeutics plc sector is Healthcare.